[{"NetIncomeLoss_1_Q1_USD":2838000.0,"PreferredStockSharesOutstanding_0_Q1_shares":0.0,"ProvisionForDoubtfulAccounts_1_Q1_USD":-21000.0,"MarketableSecuritiesCurrent_0_Q1_USD":0.0,"DepreciationAndAmortization_1_Q1_USD":3508000.0,"CommitmentsAndContingencies_0_Q1_USD":null,"GainLossOnSaleOfPropertyPlantEquipment_1_Q1_USD":-831000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-5051000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":1734000.0,"AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":333000.0,"GoodwillImpairmentLoss_1_Q1_USD":0.0,"ProductWarrantyAccrual_0_Q1_USD":0.0,"OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent_1_Q1_USD":-509000.0,"GoodwillForeignCurrencyTranslationGainLoss_1_Q1_USD":-368000.0,"AssetsCurrent_0_Q1_USD":173474000.0,"SellingGeneralAndAdministrativeExpense_1_Q1_USD":18175000.0,"ContractWithCustomerLiability_0_Q1_USD":900000.0,"CostOfGoodsAndServicesSold_1_Q1_USD":13318000.0,"StockIssuedDuringPeriodValueShareBasedCompensation_1_Q1_USD":1000.0,"CommonStockSharesIssued_0_Q1_shares":14366000.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q1_USD":0.0,"Assets_0_Q1_USD":362253000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q1_USD":-509000.0,"InterestIncomeExpenseNonoperatingNet_1_Q1_USD":-43000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":57281000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":20543000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":94599000.0,"FiniteLivedIntangibleAssetsAccumulatedAmortization_0_Q1_USD":20662000.0,"EarningsPerShareBasic_1_Q1_USD":0.2,"CapitalLeaseObligationsIncurred_1_Q1_USD":220000.0,"InventoryWriteDown_1_Q1_USD":277000.0,"FinanceLeasePrincipalPayments_1_Q1_USD":119000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q1_shares":14435000.0,"IncreaseDecreaseInAccruedLiabilities_1_Q1_USD":-1254000.0,"AccountsReceivableNetCurrent_0_Q1_USD":26509000.0,"IncomeTaxExpenseBenefit_1_Q1_USD":-1623000.0,"CommonStockValue_0_Q1_USD":144000.0,"BusinessAcquisitionsProFormaRevenue_1_Q1_USD":34292000.0,"IntangibleAssetsGrossExcludingGoodwill_0_Q1_USD":112736000.0,"EffectiveIncomeTaxRateContinuingOperations_1_Q1_pure":-1.336,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":-451000.0,"BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1_1_Q1_USD":-4820000.0,"CostsAndExpenses_1_Q1_USD":19716000.0,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":2501000.0,"IncreaseDecreaseInInventories_1_Q1_USD":4040000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q1_USD":13460000.0,"ComprehensiveIncomeNetOfTax_1_Q1_USD":2329000.0,"IncreaseDecreaseInAccountsPayable_1_Q1_USD":188000.0,"AmortizationOfIntangibleAssets_1_Q1_USD":1900000.0,"OtherAssetsNoncurrent_0_Q1_USD":20292000.0,"ShareBasedCompensation_1_Q1_USD":2259000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":6361000.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":22325000.0,"CommonStockParOrStatedValuePerShare_0_Q1_USD":0.01,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":0.0,"Goodwill_0_Q1_USD":8045000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":1215000.0,"PaymentsRelatedToTaxWithholdingForShareBasedCompensation_1_Q1_USD":332000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-2431000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q1_shares":14343000.0,"BusinessAcquisitionsProFormaNetIncomeLoss_1_Q1_USD":2838000.0,"BusinessCombinationContingentConsiderationLiabilityCurrent_0_Q1_USD":24830000.0,"LiabilitiesCurrent_0_Q1_USD":46973000.0,"AccountsPayableCurrent_0_Q1_USD":8683000.0,"EarningsPerShareDiluted_1_Q1_USD":0.2,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":9648000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":1448000.0,"IntangibleAssetsNetExcludingGoodwill_0_Q1_USD":88986000.0,"GrossProfit_1_Q1_USD":20974000.0,"WeightedAverageNumberDilutedSharesOutstandingAdjustment_1_Q1_shares":92000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":94599000.0,"DeferredIncomeTaxLiabilitiesNet_0_Q1_USD":10738000.0,"PreferredStockSharesIssued_0_Q1_shares":0.0,"CapitalExpendituresIncurredButNotYetPaid_1_Q1_USD":570000.0,"BusinessCombinationContingentConsiderationLiabilityNoncurrent_0_Q1_USD":5760000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":49131000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_1_Q1_USD":-70000.0,"CommonStockSharesOutstanding_0_Q1_shares":14366000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":2478000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":-1218000.0,"PaymentsToAcquireBusinessesNetOfCashAcquired_1_Q1_USD":350000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":-87000.0,"CommonStockSharesAuthorized_0_Q1_shares":90000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q1_USD":34292000.0,"OperatingIncomeLoss_1_Q1_USD":1258000.0,"IncreaseDecreaseInAccruedIncomeTaxesPayable_1_Q1_USD":-1242000.0,"InventoryNet_0_Q1_USD":42718000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"PreferredStockValue_0_Q1_USD":null,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":-1162000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":362253000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":5726000.0,"PreferredStockSharesAuthorized_0_Q1_shares":1250000.0,"AllocatedShareBasedCompensationExpense_1_Q1_USD":2259000.0,"ImpairmentOfIntangibleAssetsFinitelived_1_Q1_USD":0.0,"RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability_1_Q1_USD":220000.0,"OtherLiabilitiesNoncurrent_0_Q1_USD":1583000.0,"FinanceLeaseLiabilityCurrent_0_Q1_USD":119000.0,"GoodwillAcquiredDuringPeriod_1_Q1_USD":0.0,"StockholdersEquity_0_Q1_USD":276656000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":417000.0,"AllowanceForDoubtfulAccountsReceivableCurrent_0_Q1_USD":1411000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":224282000.0,"PreferredStockParOrStatedValuePerShare_0_Q1_USD":0.01,"AccruedProfessionalFeesCurrent_0_Q1_USD":2904000.0,"Ticker":"ANIK","CIK":"898437","name":"ANIKA THERAPEUTICS, INC.","OfficialName":"Anika Therapeutics Inc. Common Stock","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"337949354.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Electromedical & Electrotherapeutic Apparatus","Market":"NASDAQ","SP500":"nan","filed":"20210507"}]